Prodigiosin
-
Catalog number2311-250
-
PricePlease ask
-
Size250 ug
-
-
Alternative_name4-methoxy-5-[(Z)-(5-methyl-4-pentyl-2H-pyrrol-2-ylidene)methyl]-1H,1′H-2,2′-bipyrrole; NSC 47147; BRN 4526727
-
DescriptionIsolated from Serratia marcescens. Displays antibacterial, anticancer, cytotoxic, immunosuppressive, and antiproliferative activities. Prodigiosin induces apoptosis in hematopoietic cancer cells and cells derived from other human cancers, including gastric and colon with no marked toxicity in nonmalignant cell lines. Also acts as a mTORC1 and mTORC2 complex inhibitor.
-
CAS Number82-89-3
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₀H₂₅N₃O
-
Molecular Weight323.43
-
Cell PermeableYes
-
Purity≥95% by HPLC
-
SolubilitiesDMSO or Ethanol
-
HandlingProtect from air and light
-
Tag LineA mTORC1 and mTORC2 complex inhibitor.
-
Storage Condition-20 ̊C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
PubChem CID5351169
-
SMILESCCCCCC1=C(NC(=C1)C=C2C(=CC(=C3C=CC=N3)N2)OC)C
-
InChiInChI=1S/C20H25N3O/c1-4-5-6-8-15-11-16(22-14(15)2)12-19-20(24-3)13-18(23-19)17-9-7-10-21-17/h7,9-13,22-23H,4-6,8H2,1-3H3/b18-17-,19-12-
-
InChi KeyWKGQSEFBQTWRPT-UUPRNIFOSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameProdigiosin
-
Alternative nameProdigiosin
-